| __timestamp | Alpine Immune Sciences, Inc. | Axsome Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 4279200 |
| Thursday, January 1, 2015 | 16054000 | 6776987 |
| Friday, January 1, 2016 | 23316000 | 21199860 |
| Sunday, January 1, 2017 | 10626000 | 19957616 |
| Monday, January 1, 2018 | 28970000 | 23495055 |
| Tuesday, January 1, 2019 | 35847000 | 53647067 |
| Wednesday, January 1, 2020 | 27185000 | 70244579 |
| Friday, January 1, 2021 | 58742000 | 58060725 |
| Saturday, January 1, 2022 | 70243000 | 57947447 |
| Sunday, January 1, 2023 | 80904000 | 97944000 |
| Monday, January 1, 2024 | 187077000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) investments are crucial for driving innovation and growth. Over the past decade, Axsome Therapeutics, Inc. and Alpine Immune Sciences, Inc. have demonstrated significant commitment to R&D, with both companies showing a steady increase in their investments.
From 2014 to 2023, Axsome Therapeutics increased its R&D spending by over 2,000%, peaking in 2023 with an investment of nearly $98 million. This surge underscores Axsome's aggressive pursuit of new therapeutic solutions. Meanwhile, Alpine Immune Sciences also ramped up its R&D efforts, with a notable 563% increase over the same period, reaching approximately $81 million in 2023.
These investments highlight the companies' dedication to advancing medical science and improving patient outcomes, positioning them as leaders in the biotech industry.
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Axsome Therapeutics, Inc.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
R&D Spending Showdown: Genmab A/S vs Axsome Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.